ID: ALA5170100

Max Phase: Preclinical

Molecular Formula: C40H60N4Na2O20S2

Molecular Weight: 983.08

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@@](OCCCSCCNC(=O)c2ccc(C(=O)NCCSCCCO[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)cc2)(C(=O)[O-])C[C@@H]1O.[Na+].[Na+]

Standard InChI:  InChI=1S/C40H62N4O20S2.2Na/c1-21(47)43-29-25(49)17-39(37(57)58,63-33(29)31(53)27(51)19-45)61-11-3-13-65-15-9-41-35(55)23-5-7-24(8-6-23)36(56)42-10-16-66-14-4-12-62-40(38(59)60)18-26(50)30(44-22(2)48)34(64-40)32(54)28(52)20-46;;/h5-8,25-34,45-46,49-54H,3-4,9-20H2,1-2H3,(H,41,55)(H,42,56)(H,43,47)(H,44,48)(H,57,58)(H,59,60);;/q;2*+1/p-2/t25-,26-,27+,28+,29+,30+,31+,32+,33+,34+,39+,40+;;/m0../s1

Standard InChI Key:  XCMCXTAXWOBGKN-GMPVQRATSA-L

Associated Targets(Human)

CD22 125 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 983.08Molecular Weight (Monoisotopic): 982.3399AlogP: -4.28#Rotatable Bonds: 28
Polar Surface Area: 389.76Molecular Species: ACIDHBA: 20HBD: 14
#RO5 Violations: 3HBA (Lipinski): 24HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 2.91CX Basic pKa: CX LogP: -4.57CX LogD: -11.45
Aromatic Rings: 1Heavy Atoms: 66QED Weighted: 0.04Np Likeness Score: 0.16

References

1. Prescher H, Schweizer A, Frank M, Kuhfeldt E, Ring J, Nitschke L..  (2022)  Targeting Human CD22/Siglec-2 with Dimeric Sialosides as Novel Oligosaccharide Mimetics.,  65  (15.0): [PMID:35881556] [10.1021/acs.jmedchem.2c00765]

Source